|
US7070777B1
(en)
|
1991-11-15 |
2006-07-04 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting inflammation with an antibody that binds the 5C8 protein
|
|
US5474771A
(en)
|
1991-11-15 |
1995-12-12 |
The Trustees Of Columbia University In The City Of New York |
Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
|
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
|
US6340459B1
(en)
|
1995-12-01 |
2002-01-22 |
The Trustees Of Columbia University In The City Of New York |
Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients
|
|
TW517061B
(en)
|
1996-03-29 |
2003-01-11 |
Pharmacia & Amp Upjohn Ab |
Modified/chimeric superantigens and their use
|
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
KR20000070034A
(ko)
|
1997-01-10 |
2000-11-25 |
아스트루 마이클 제이 |
항 ｃｄ40ｌ 화합물로 신염성 루푸스를 치료하는 방법
|
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
CN1202864C
(zh)
|
1997-05-17 |
2005-05-25 |
拜奥根有限公司 |
Cd40:cd154结合阻断物在制备预防逆适应性免疫应答,特别是移植物排斥反应的药物中的用途
|
|
WO1998058672A1
(en)
|
1997-06-20 |
1998-12-30 |
Biogen, Inc. |
Cd154 blockade therapy for therapeutic protein inhibitor syndrome
|
|
BR9810620A
(pt)
|
1997-06-20 |
2000-10-03 |
Biogen Inc |
Terapia de bloqueio de cd154 para transplante de tecido da ilhota pancreática
|
|
NZ518483A
(en)
|
1999-10-22 |
2004-03-26 |
Biogen Inc |
Use of CD40:CD154 binding interruptor to treat immunological complications of the eye
|
|
US8101553B1
(en)
|
2000-02-22 |
2012-01-24 |
Medical & Biological Laboratories Co., Ltd. |
Antibody library
|
|
GB0019820D0
(en)
|
2000-08-12 |
2000-09-27 |
Koninkl Philips Electronics Nv |
Selective delivery of data
|
|
FI112501B
(fi)
|
2001-05-18 |
2003-12-15 |
Valtion Teknillinen |
Heveiiniä sitovat monoklonaaliset vasta-aineet
|
|
ES2316574T3
(es)
|
2001-06-12 |
2009-04-16 |
Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute |
Anticuerpo de tipo humano contra el factor viii de la coagulacion sanguinea.
|
|
EP1439192A1
(en)
|
2003-01-15 |
2004-07-21 |
Xerion Pharmaceuticals AG |
Neuropilin-1 inhibitors
|
|
GB0315450D0
(en)
|
2003-07-01 |
2003-08-06 |
Celltech R&D Ltd |
Biological products
|
|
KR20060090651A
(ko)
|
2003-07-03 |
2006-08-14 |
유니크롭 엘티디 |
신규한 루비스코 프로모터 및 이의 용도
|
|
CN101031588A
(zh)
|
2004-06-01 |
2007-09-05 |
多曼蒂斯有限公司 |
药物组合物，融合物和结合物
|
|
EA012622B1
(ru)
|
2004-06-01 |
2009-10-30 |
Домэнтис Лимитед |
Биспецифичные гибридные антитела с увеличенным периодом полувыведения из сыворотки
|
|
EA014226B1
(ru)
|
2004-07-26 |
2010-10-29 |
Байоджен Айдек Ма Инк. |
Антитела к cd154, их фрагменты и способы применения антител и фрагментов
|
|
BRPI0514259A
(pt)
|
2004-08-11 |
2008-06-03 |
Trubion Pharmaceuticals Inc |
proteìna de fusão de domìnio de ligação
|
|
JP2008515889A
(ja)
|
2004-10-05 |
2008-05-15 |
ジェネンテック・インコーポレーテッド |
毒性の低下した治療剤
|
|
EP2024396A2
(en)
|
2004-12-02 |
2009-02-18 |
Domantis Limited |
Plad domain peptides with increased serum half life due to conjugation to domain antibodies
|
|
US8709219B2
(en)
|
2005-03-10 |
2014-04-29 |
Panasonic Corporation |
Structured diamond tool made by focused ion beam nanomachining
|
|
WO2006124269A2
(en)
|
2005-05-16 |
2006-11-23 |
Amgen Fremont Inc. |
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
JP4940013B2
(ja)
|
2006-07-31 |
2012-05-30 |
富士通株式会社 |
半導体装置に対する同時動作信号ノイズ見積り方法、およびプログラム
|
|
CL2007002225A1
(es)
|
2006-08-03 |
2008-04-18 |
Astrazeneca Ab |
Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
|
|
KR20120017469A
(ko)
|
2007-01-05 |
2012-02-28 |
유니버시티 오브 취리히 |
질환 특이적 결합 분자 및 표적을 제공하는 방법
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
PT2125894T
(pt)
|
2007-03-22 |
2019-02-27 |
Biogen Ma Inc |
Proteínas de ligação incluindo anticorpos, derivados de anticorpos e fragmentos de anticorpos que se ligam especificamente ao cd154 e as suas utilizações
|
|
WO2008127655A1
(en)
|
2007-04-13 |
2008-10-23 |
Biogen Idec Ma Inc. |
Anti-alpha 6 beta 4 integrin antibodies and uses therof
|
|
AU2008261042A1
(en)
|
2007-06-08 |
2008-12-11 |
Dow Global Technologies Inc. |
Expression of soluble antibody fragment by truncation of CH1 domain
|
|
WO2009002380A2
(en)
|
2007-06-26 |
2008-12-31 |
The Trustees Of The University Of Pennsylvania |
Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies
|
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
|
US20110033476A1
(en)
|
2007-11-12 |
2011-02-10 |
Theraclone Sciences Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
WO2009082624A2
(en)
|
2007-12-10 |
2009-07-02 |
Zymogenetics, Inc. |
Antagonists of il-17a, il-17f, and il-23 and methods of using the same
|
|
WO2009120922A2
(en)
|
2008-03-27 |
2009-10-01 |
Zymogenetics, Inc. |
Compositions and methods for inhibiting pdgfrbeta and vegf-a
|
|
CA2721093A1
(en)
|
2008-04-11 |
2009-10-15 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|
|
CA2730073A1
(en)
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
WO2010014854A2
(en)
|
2008-07-31 |
2010-02-04 |
The Regents Of The University Of California |
Antibodies that neutralize botulinum neurotoxins
|
|
CA2737667A1
(en)
|
2008-09-19 |
2010-03-25 |
Medimmune, Llc |
Targeted binding agents directed to cd105 and uses thereof
|
|
HRP20170374T1
(hr)
|
2008-09-26 |
2017-05-05 |
Ucb Biopharma Sprl |
Biološki proizvodi
|
|
KR101740066B1
(ko)
|
2008-12-05 |
2017-05-25 |
글락소 그룹 리미티드 |
프로테아제 저항성 폴리펩티드를 선택하는 방법
|
|
JP2012527473A
(ja)
|
2009-05-20 |
2012-11-08 |
セラクローン サイエンシーズ， インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
|
JP6086528B2
(ja)
|
2009-08-06 |
2017-03-01 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
長期のインビボ有効性を有する成長ホルモン
|
|
US8974788B2
(en)
|
2009-08-14 |
2015-03-10 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
MX358013B
(es)
|
2009-11-13 |
2018-08-01 |
Amgen Inc |
Materiales y metodos para el tratamiento o prevencion de enfermedades asociadas al her-3.
|
|
SI2501817T2
(sl)
|
2010-02-08 |
2021-09-30 |
Regeneron Pharmaceuticals, Inc. |
Miš z navadno lahko verigo
|
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
|
US20130185821A1
(en)
|
2010-02-08 |
2013-07-18 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
|
EP3165540A1
(en)
|
2010-04-13 |
2017-05-10 |
Celldex Therapeutics, Inc. |
Antibodies that bind human cd27 and uses thereof
|
|
US20120213771A1
(en)
|
2010-04-13 |
2012-08-23 |
Celldex Therapeutics Inc. |
Antibodies that bind human cd27 and uses thereof
|
|
AU2011286407A1
(en)
|
2010-08-06 |
2013-02-21 |
Amgen |
Use of HER3 binding agents in prostate treatment
|
|
AU2012205663B2
(en)
|
2011-01-10 |
2017-02-02 |
Emory University |
Antibodies directed against influenza
|
|
JP2014506580A
(ja)
|
2011-02-14 |
2014-03-17 |
セラクローン サイエンシーズ， インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
|
SG193402A1
(en)
|
2011-03-15 |
2013-10-30 |
Theraclone Sciences Inc |
Compositions and methods for the therapy and diagnosis of influenza
|
|
BR112013026828A2
(pt)
|
2011-04-21 |
2016-11-29 |
Bristol Myers Squibb Co |
polipeptídeos de anticorpo que antagonizam cd40
|
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
|
WO2012158818A2
(en)
*
|
2011-05-16 |
2012-11-22 |
Fabion Pharmaceuticals, Inc. |
Multi-specific fab fusion proteins and methods of use
|
|
BR112013031485B1
(pt)
|
2011-06-10 |
2022-06-14 |
Medimmune, Llc |
Anticorpo monoclonal isolado ou fragmento de ligação a antígeno do mesmo, composição farmacêutica, usos e método in vitro para bloqueio ou prevenção da ligação de p. aeruginosa a células epiteliais
|
|
RS59728B1
(sr)
|
2011-08-05 |
2020-02-28 |
Regeneron Pharma |
Humanizovani miševi univerzalnog lakog lanca
|
|
SMT202000091T1
(it)
*
|
2011-10-13 |
2020-05-08 |
Bristol Myers Squibb Co |
Polipeptidi anticorpali che antagonizzano cd40l
|
|
JP5413432B2
(ja)
|
2011-10-20 |
2014-02-12 |
コニカミノルタ株式会社 |
画像形成装置
|
|
BR112014011028B1
(pt)
|
2011-11-07 |
2021-03-02 |
Medimmune, Llc |
anticorpo biespecífico, composição, e, uso da composição
|
|
ES2842201T3
(es)
|
2012-02-23 |
2021-07-13 |
Daiichi Sankyo Europe Gmbh |
Inhibidor de HER3 para modulación de radiosensibilidad
|
|
IN2014DN08163A
(https=)
|
2012-03-06 |
2015-05-01 |
Regeneron Pharma |
|
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
|
EA039663B1
(ru)
|
2012-05-03 |
2022-02-24 |
Амген Инк. |
Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств
|
|
JP2015520172A
(ja)
|
2012-05-31 |
2015-07-16 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
Ｄｌｌ−４に結合する抗原結合蛋白質
|
|
HK1204557A1
(en)
|
2012-05-31 |
2015-11-27 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind pd-l1
|
|
RU2014153674A
(ru)
|
2012-06-05 |
2016-07-27 |
Регенерон Фармасьютикалз, Инк. |
Способ получения полностью человеческих биспецифических антител с применением общей легкой цепи
|
|
JO3462B1
(ar)
|
2012-08-22 |
2020-07-05 |
Regeneron Pharma |
أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
JP2015535005A
(ja)
|
2012-11-06 |
2015-12-07 |
メディミューン，エルエルシー |
抗シュードモナス属（Ｐｓｅｕｄｏｍｏｎａｓ）ＰｓｌおよびＰｃｒＶ結合分子を用いた併用治療
|
|
CN105189545A
(zh)
|
2013-03-13 |
2015-12-23 |
瑞泽恩制药公司 |
常见轻链小鼠
|
|
WO2014160202A1
(en)
|
2013-03-13 |
2014-10-02 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
US20160032014A1
(en)
|
2013-03-15 |
2016-02-04 |
Amgen Inc. |
Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
|
|
JP2016519688A
(ja)
|
2013-04-22 |
2016-07-07 |
セラクローン サイエンシーズ， インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
|
JP6267792B2
(ja)
|
2013-06-28 |
2018-01-24 |
アムジエン・インコーポレーテツド |
ホモ接合性家族性高コレステロール血症の治療方法
|
|
TW201920262A
(zh)
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素ａ之抗體及其用途
|
|
MX371328B
(es)
*
|
2013-08-30 |
2020-01-27 |
Aprilbio Co Ltd |
Constructo de fusion de la fraccion efectora del fragmento de union a antigeno (fab) de anti-albumina de suero y su metodo de preparacion.
|
|
TWI681969B
(zh)
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對ｐｄ-１的人類抗體
|
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗ｐｄ-ｌ１之人類抗體
|
|
KR102399277B1
(ko)
|
2014-04-10 |
2022-05-18 |
다이이찌 산쿄 가부시키가이샤 |
항her3 항체-약물 콘주게이트
|
|
JO3701B1
(ar)
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
|
GB201411320D0
(en)
|
2014-06-25 |
2014-08-06 |
Ucb Biopharma Sprl |
Antibody construct
|
|
SG10201913084PA
(en)
|
2014-09-23 |
2020-03-30 |
Regeneron Pharma |
Anti-il-25 antibodies and uses thereof
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
|
MA41459A
(fr)
*
|
2015-02-03 |
2017-12-12 |
Als Therapy Development Inst |
Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l
|
|
WO2016135239A1
(en)
*
|
2015-02-25 |
2016-09-01 |
Biotecnol Limited |
Fusion protein comprising three binding domains to her2
|
|
EP3271403A1
(en)
|
2015-03-19 |
2018-01-24 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|
|
US11597778B2
(en)
|
2015-04-07 |
2023-03-07 |
The Trustees Of The University Of Pennsylvania |
Human monoclonal autoantibodies to ADAMTS13 and uses thereof
|
|
EA201792573A1
(ru)
*
|
2015-05-21 |
2018-04-30 |
Харпун Терапьютикс, Инк. |
Триспецифические связанные белки и способы их применения
|
|
TW201702272A
(zh)
|
2015-05-22 |
2017-01-16 |
美國紀念斯隆 凱特琳癌症中心 |
Ｐｒａｍｅ肽專一性類ｔ細胞受體抗體
|
|
US11359010B2
(en)
|
2015-07-13 |
2022-06-14 |
UNIVERSITé LAVAL |
Humanized anti-S100A9 antibody and uses thereof
|
|
JOP20160154B1
(ar)
|
2015-07-31 |
2021-08-17 |
Regeneron Pharma |
أجسام ضادة مضاد لل psma، وجزيئات رابطة لمستضد ثنائي النوعية الذي يربط psma و cd3، واستخداماتها
|
|
TW201713690A
(zh)
|
2015-08-07 |
2017-04-16 |
再生元醫藥公司 |
抗ａｎｇｐｔｌ８抗體及其用途
|
|
LT3353212T
(lt)
|
2015-09-23 |
2021-12-27 |
Regeneron Pharmaceuticals, Inc. |
Optimizuoti anti-cd3 bispecifiniai antikūnai ir jų naudojimas
|
|
CA2997444A1
(en)
|
2015-09-29 |
2017-04-06 |
Amgen Inc. |
Asgr inhibitors for reducing cholesterol levels
|
|
TWI756187B
(zh)
|
2015-10-09 |
2022-03-01 |
美商再生元醫藥公司 |
抗ｌａｇ３抗體及其用途
|
|
TW202417497A
(zh)
|
2015-10-12 |
2024-05-01 |
美商再生元醫藥公司 |
活化瘦素受體的抗原結合蛋白
|
|
CR20180365A
(es)
|
2015-12-16 |
2018-09-28 |
Amgen Inc |
PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS
|
|
GB201522391D0
(en)
*
|
2015-12-18 |
2016-02-03 |
Ucb Biopharma Sprl |
Antibody molecules
|
|
CN109476756B
(zh)
*
|
2016-03-15 |
2022-05-31 |
埃泰美德(香港)有限公司 |
一种多特异性Fab融合蛋白及其用途
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448875A4
(en)
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
IL323024A
(en)
|
2016-05-20 |
2025-10-01 |
Regeneron Pharma |
Methods for breaking immunological tolerance using multiple guide RNAs
|
|
US10738126B2
(en)
|
2016-06-10 |
2020-08-11 |
Regeneron Pharmaceuticals, Inc. |
Anti-GITR antibodies and uses thereof
|
|
SI3468586T1
(sl)
|
2016-06-14 |
2025-01-31 |
Xencor, Inc. |
Bispecifična protitelesa za zaviralce kontrolnih točk
|
|
ES2984352T3
(es)
|
2016-06-14 |
2024-10-29 |
Regeneron Pharma |
Anticuerpos anti-C5 y usos de los mismos
|
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
|
WO2018009732A1
(en)
|
2016-07-08 |
2018-01-11 |
Regeneron Pharmaceuticals, Inc. |
Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertension
|
|
EP3489262A4
(en)
|
2016-07-19 |
2020-07-08 |
Ibentrus, Inc. |
BISPECIFIC PROTEINS AND PROCESSES FOR THEIR PREPARATION
|
|
WO2018045110A1
(en)
|
2016-08-30 |
2018-03-08 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
|
US10793632B2
(en)
|
2016-08-30 |
2020-10-06 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
|
MX2019003325A
(es)
|
2016-09-23 |
2019-08-05 |
Regeneron Pharma |
Anticuerpos anti-steap2, conjugados anticuerpo-farmaco, y moleculas de fijacion al antigeno biespecificas que se fijan a steap2 y cd3, y usos de estos.
|
|
MY194596A
(en)
|
2016-09-23 |
2022-12-06 |
Regeneron Pharma |
Bi Specific Anti-Muc16-CD3 Antibodies And Anti-Muc16 Drug Conjugates
|
|
US11667697B2
(en)
|
2016-10-19 |
2023-06-06 |
Vanderbilt University |
Human orthopoxvirus antibodies and methods of use therefor
|
|
US10550192B2
(en)
|
2016-11-08 |
2020-02-04 |
Regeneron Pharmaceuticals, Inc. |
Antigen-binding proteins that antagonize leptin receptor
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
WO2018094112A1
(en)
|
2016-11-17 |
2018-05-24 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating obesity with anti-angptl8 antibodies
|
|
EP3548515B1
(en)
|
2016-12-01 |
2026-01-21 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
|
|
WO2018115859A1
(en)
|
2016-12-20 |
2018-06-28 |
Kymab Limited |
Multispecific antibody with combination therapy for immuno-oncology
|
|
TW202311284A
(zh)
|
2017-01-03 |
2023-03-16 |
美商再生元醫藥公司 |
抗金黃色葡萄球菌溶血素ａ毒素之人類抗體
|
|
CA3053348A1
(en)
|
2017-02-10 |
2018-08-16 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled anti-lag3 antibodies for immuno-pet imaging
|
|
CN110662768B
(zh)
|
2017-05-24 |
2024-01-30 |
Als治疗发展学会 |
治疗性抗cd40配体抗体
|
|
KR20200018781A
(ko)
*
|
2017-06-19 |
2020-02-20 |
스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) |
반감기 연장 폴리펩티드를 갖는 융합 단백질
|
|
WO2019201866A1
(en)
|
2018-04-16 |
2019-10-24 |
Swedish Orphan Biovitrum Ab (Publ) |
Fusion protein
|
|
WO2021006604A1
(ko)
|
2019-07-08 |
2021-01-14 |
주식회사 프로젠 |
신규 융합단백질 및 그의 용도
|
|
KR20210095781A
(ko)
*
|
2020-01-24 |
2021-08-03 |
주식회사 에이프릴바이오 |
항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
|